Alejandro Forner

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Cancer Biology Cancer Biology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Alessio Aghemo

ITALY

View details

Edoardo G. Giannini

University of Genoa

ITALY

View details

David J. Pinato

Imperial College London

UNITED KINGDOM

View details

Carlos Moctezuma-Velazquez

Assistant Professor

University of Alberta

CANADA

View details

Álvaro Díaz‐González

SPAIN

View details

Helen Reeves

Professor of Liver Cancer

Newcastle University

UNITED KINGDOM

View details

José Ríos

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Federica Grillo

Assistant Professor

University of Genoa

ITALY

View details

Mohamed bouattour

Head of Unit

FRANCE

View details

Chiara Braconi

University of Glasgow

UNITED KINGDOM

View details

Jordi Rimola

University of Barcelona

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alejandro Forner

Research Interests

Explore related searches

Contact this professor

Articles (10)

Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma

Immunotherapy in biliary tract cancer: The race has begun!

Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients—A Multiparametric Prediction

Should Artificial Intelligence‐based language models be allowed in developing scientific manuscripts? A debate between ChatGPT and the editors of Liver International

New Challenges in the Management of Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy

Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study.

Barcelona Clinic Liver Cancer 2022 update: Linking prognosis prediction and evidence‐based treatment recommendation with multidisciplinary clinical decision‐making

Low Baseline Plasma L-Glutamine Concentration Identifies Hepatocellular Carcinoma Patients at High Risk of Developing Early Gastrointestinal Adverse Events during Sorafenib Treatment

Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

Collaborators (11)

Alessio Aghemo

Edoardo G. Giannini

David J. Pinato

Carlos Moctezuma-Velazquez

Álvaro Díaz‐González

Helen Reeves

José Ríos

Federica Grillo

Mohamed bouattour

Chiara Braconi

Jordi Rimola

Make your next move.